Mid-Day Commentary & Reports For: (PINK:AONEQ), (OTC:AMBS), (OTC:FNMA), (PINK:MJNA)


New York, NY -- (ReleaseWire) -- 11/08/2012 --A123 Systems Inc. (PINK:AONEQ) is down sharply in mid-day trading. The stock is currently down 12.44% to $0.0845 on volume of 9.77 million. AONEQ has fallen sharply since the company filed for bankruptcy last month. The stock has also been delisted from the NASDAQ stock market. AONEQ has fallen below $0.10 support level. The downward slide could continue before the stock finds support at around $0.05.

Today, the government’s bankruptcy watchdog said that A123 Systems Inc.’s tried to pay incentive bonuses to a handful of the battery maker’s. Find out how this announcement could affect the stock by getting the full trend analysis report here:

Amarantus BioSciences Inc. (OTC:AMBS) is down sharply in mid-day trading today, paring some of the recent gains. The stock is currently down 24.64% to $0.0370 on volume of 28.29 million, which is more than two times the daily average volume of 13.84 million.

AMBS has seen a sharp correction in the last two trading sessions after posting significant gains in the prior sessions. The stock has now fallen below its 200-day moving average, which is a bearish signal. The sharp drop in the last two days has been accompanied by significantly high volume, which further confirms that the market sentiment has turned bearish on AMBS. The stock’s MACD chart is also giving bearish signals.

Find out when will be the best moment to trade AMBS by reading the full trend analysis report here:

Fannie Mae (OTC:FNMA) is down sharply in mid-day trading today. At last check, the stock was trading 2.06% lower at $0.290 on volume of 6.76 million, which is nearly four times the daily average volume of 1.84 million. The sharp drop in FNMA on significantly higher volume suggests that the market sentiment has turned bearish on the stock. FNMA had risen sharply following the release of its quarterly results. However, prior to the sharp rise, the stock had been trading sideways. The stock has slipped after hitting $0.30, which has been a stiff resistance level.

Yesterday, Fannie Mae announced that for its Q3, the company made a net income of $1.8B. Could this announcement help FNMA reach new heights or will the stock maintain today’s losing momentum? Get the answers by reading the full trend analysis report here:

Medical Marijuana Inc. (PINK:MJNA) is down sharply in mid-day trading today. The stock is currently down 8.63% to $0.127 on volume of 8.43 million, which is above the daily average volume of 8.18 million.

The sharp decline in MJNA today has revered some of the gains from earlier in the week. MJNA had risen sharply on some positive developments for the medical marijuana industry. The stock’s MACD histogram indicates that the recent bullish trend is coming to an end. MJNA has support at around $0.12. If the stock falls below this level then the downward slide is likely to continue in the next few trading sessions.

WallStreetReport.Net has been following MJNA for the last couple of months providing traders with the best analysis reports. Find out how to benefit from this knowledge by reading the free trend analysis report here:

About issues momentum alerts on stocks that can provide gains to day traders. provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors you to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here:

Disclosure is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.

Contact Info:
Alexander K. Neumann